The purpose of the Medicaid Pharmaceutical & Therapeutics Committee is to develop and implement a voluntary Medicaid preferred prescribed drug designation program, as mandated in the 2000 session of the Florida legislature, SB 2034.
Florida Statute 409.91195 requires the appointment of committee by the Governor.
Information regarding the next scheduled meetings for the Pharmaceutical & Terapeutics Committee can be found at the Pharmacy Meeting Notices web page.
The Florida Medicaid Preferred Drug List (PDL) is a listing of prescription products selected by the Pharmaceutical & Therapeutics Committee as cost effective choices for clinician consideration when prescribing for Medicaid recipients. The PDL will be used to inform clinicians of effective products that provide favorable net costs to Medicaid. The PDL educates clinicians about cost effective choices in prescribing for Medicaid recipients, but clinicians always retain the option of selecting the drug product they feel is most appropriate for their patient by calling the Therapeutic Consultation Program at (877) 553-7481. If the prescriber cannot readily obtain authorization the pharmacist may dispense a 72 hour supply. The pharmacist may also use their professional judgment if other situations arise that would necessitate a 72 hour emergency supply.